Translate this page into:
Wilson’s disease presenting as osmotic demyelination syndrome
[To cite: Singh R, Peer S, Dhoot S, Goel A, Wander A. Wilson’s disease presenting as osmotic demyelination syndrome. Natl Med J India 2026;39:271-2. DOI: 10.25259/NMJI_588_2024]
A 12-year-old girl from a poor socio-economic background presented in the emergency department in a minimally conscious state for 2 days. She was taking complementary and alternative medicines for 2 years because of behavioural and psychiatric issues. On examination, there was diffuse rigidity in all limbs. Liver function tests were deranged,with bilirubin of 3 mg/dl and alanine aminotransferase of 80 IU/dl. Serum electrolytes were normal. MRI of the brain (Fig. 1) showed typical features of osmotic demyelination syndrome (ODS), including T2/Fluid attenuation inversion recovery (FLAIR) hyperintensity in the bilateral basal ganglia and the midbrain tegmentum, for which Wilson disease, mitochondrial disorders, and other metabolic disorders were the differential diagnoses. Infection and toxin workup was negative. The patient was given pulse methylprednisolone, resulting in gradual improvement.1 Further workup revealed reduced serum ceruloplasmin (11.8 mg/dl; normal: 20–55), raised serum copper (165 μg/dl; normal: 80–155), and urinary copper excretion (212 μg/24 hours; normal: 3–35). Ophthalmological examination showed the presence of Kayser-Fleischer ring (Fig. 2). Ultrasound showed coarse liver echotexture. Thus, the diagnosis of Wilson’s disease was confirmed, and the patient was started on penicillamine and zinc therapy. ODS in this patient was likely due to malnutrition and liver dysfunction. Abnormal signals in the central pons are also seen in Wilson’s disease; whether these changes differ from those of ODS remains unclear.2 Due to its varied presentation, ODS often goes unnoticed initially in most cases.3 Therefore, prompt diagnosis is crucial to prevent potential complications. The patient responded to steroids before starting de-coppering therapy, which favours demyelination in the background of Wilson’s disease.


Conflicts of interest.
None declared
References
- Osmotic demyelination syndrome improving after immune-modulating treatment: Case report and literature review. Clin Neurol Neurosurg. 2021;208:106811.
- [CrossRef] [PubMed] [Google Scholar]
- Central pontine signal changes in Wilson's disease: Distinct MRI morphology and sequential changes with de-coppering therapy. J Neuroimaging. 2007;17:286-91.
- [CrossRef] [PubMed] [Google Scholar]
- Central pontine and extrapontine myelinolysis: A systematic review. Eur J Neurol. 2014;21:1443-50.
- [CrossRef] [PubMed] [Google Scholar]